Drug Chatter -- Tracking biopharma stock chatter

💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch

Profile for Immunomedics, Inc. (IMMU)

« Back to company index

IMMU Chatter Timeline

Stock Ticker for IMMU

Most Active Tweeters for IMMU

No tweets found

Recent Tweets for IMMU

biotechradar_eu @biotechradar_eu
Mendus $IMMU to host key opinion leader event on immunotherapy for maintenance treatment of Acute Myeloid Leukemia… https://t.co/7gXvL24pSx
November 16th 2022, 9:11am
AnalyserNU @AnalyserNU
Analys - Mendus No surprises in Q3 as DCP-001 readout nears https://t.co/5uMUbNr6mT $IMMU #aktieanalys
November 14th 2022, 8:11am
Biopharmaddict @Biopharmaddict
@Leo09416981 Yep, thank you! I mean "a la" as in decks from Sarissa Capital like those filed for $IMMU and $VRX… https://t.co/FO3IvlFA20
November 9th 2022, 10:11pm
biotechradar_eu @biotechradar_eu
Mendus $IMMU to present data at SITC 2022 demonstrating the potential of the DCOne platform to expand memory NK cel… https://t.co/BB53PI0AcQ
November 8th 2022, 8:11am
SADIFAnalytics @SADIFAnalytics
Rating Update for Mendus AB (publ) $IMMU https://t.co/ckza9GwwQ0
November 7th 2022, 5:11pm
BurchetJohn @BurchetJohn
@SCalifornee @pawcio2009 Too bad you didn't hold $IMMU a bit longer...$88 BO.
November 7th 2022, 1:11pm
ziggles89 @ziggles89
RT @BertrandBio: $IMMU Use of an Allogeneic Leukemia-Derived Dendritic Cell Vaccine in MRD+ AML-Patients Results in MRD Conversion, Improve…
November 3rd 2022, 10:11pm
BertrandBio @BertrandBio
$IMMU Induction of a Systemic Immune Response during Use of an Allogenic Leukemia-Derived Dendritic Cell Vaccine in… https://t.co/jO2NZPwA7n
November 3rd 2022, 6:11pm
BertrandBio @BertrandBio
$IMMU Use of an Allogeneic Leukemia-Derived Dendritic Cell Vaccine in MRD+ AML-Patients Results in MRD Conversion,… https://t.co/TZYzk55DVd
November 3rd 2022, 6:11pm
biotechradar_eu @biotechradar_eu
Mendus $IMMU to present multiple abstracts at ASH 2022 including an oral presentation of updated AML survival resul… https://t.co/3GNfjIPpj1
November 3rd 2022, 3:11pm
biotechradar_eu @biotechradar_eu
Mendus $IMMU to participate in upcoming conferences in November https://t.co/H8mYvC6gD0
November 1st 2022, 2:11pm
AlanGormican @AlanGormican
@sharkbiotech Long $immu
October 28th 2022, 12:10pm
AnalyserNU @AnalyserNU
Analys - Mendus Funding to see through key inflection points https://t.co/f8oDffcTSY $IMMU #aktieanalys
October 27th 2022, 8:10am
biotechradar_eu @biotechradar_eu
Mendus $IMMU secures first shareholder loan from Van Herk Investments and signs final documentation with Negma Group https://t.co/EpVLUx9b0p
October 26th 2022, 8:10am
ej23ny @ej23ny
Most recent activist contests venBio Vs $IMMU win for VenBio appointed 4 directors Velan Capital Vs $RDUS acquir… https://t.co/jC3md4PXog
October 24th 2022, 3:10pm
KempenLS @KempenLS
#ECTRIMS2022: 26-28 Oct #ESGO2022: 27-30 Oct - $IMMU: DCP-001 ph1 ovarian cancer data - 27 Oct Roadshows $GNFT: Vi… https://t.co/JdfkBv8kIK
October 24th 2022, 6:10am
BurchetJohn @BurchetJohn
@pharmacreep Look what happened a couple years ago with $IMMU. It's possible $PRVB is next.
October 22nd 2022, 1:10pm
biotechradar_eu @biotechradar_eu
Mendus $IMMU secures manufacturing partner for establishing potential pivotal trial-stage and commercial production… https://t.co/aObazmhLes
October 18th 2022, 8:10am
biotechradar_eu @biotechradar_eu
Mendus $IMMU to report positive clinical and preclinical data in ovarian cancer at the European Society of Gynaecol… https://t.co/BIPa6NeTyq
October 17th 2022, 9:10am
macroaxis @macroaxis
IMMUNOMEDICS INC ( $IMMU ) social hype UNDER HYPED. Current chance of bankruptcy is under 54%… https://t.co/wm4AzVyLc0
October 12th 2022, 3:10pm
biotechradar_eu @biotechradar_eu
Mendus $IMMU to receive final payment as a result of the completion of the EU Horizon 2020 AML-VACCiN project https://t.co/vesro23o9s
October 12th 2022, 10:10am
ej23ny @ej23ny
proxy fight Activist Vs biotech Management ! Ven Advisor LLC Vs $IMMU ! 55% of /80% Cast the vote in Favor of ven… https://t.co/UblI5sqC44
October 11th 2022, 9:10pm
macroaxis @macroaxis
Immunomedics ( $IMMU ) social hype UNDER HYPED. Current odds of distress is under 54% https://t.co/5166DvQHOe #biotech #stocks #fintech
September 27th 2022, 3:09pm
biotechradar_eu @biotechradar_eu
Mendus $IMMU Mendus to participate in upcoming conferences in September https://t.co/l7mhekeZBh
September 1st 2022, 6:09am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.